Covance

Phase Forward Agrees to $10M Acquisition, Multi-Year Partnership with Covance

Wednesday, July 15, 2009 01:30 PM

Covance is selling its interactive voice and web response services (IVR/IWR) business to eClinical provider Phase Forward for $10 million cash, and the two companies have entered into a multi-year agreement making Phase Forward a preferred provider for the contract research organization (CRO).

More... »

CROs See Brighter Future Despite Cancellations

Monday, May 4, 2009 08:00 AM

Contract research organizations (CROs) continue to feel the adverse effects of cancellations and negative foreign exchange, but their most recent earnings reports show some promise.

More... »

Covance's Q1 Profit Drops, Cuts 2009 Forecast

Thursday, April 30, 2009 07:10 AM

Covance's first quarter profit fell 18%, and the company reduced its 2009 profit guidance. In after hours trading, Covance's shares fell 8.2% to $37.

More... »

Covance Expands in Latin America

Tuesday, April 14, 2009 07:48 AM

Covance opened new clinical development offices in Santiago, Chile, and Lima, Peru, and expanded its office in Buenos Aires, Argentina, increasing the contract research organization (CRO)’s presence in Latin America.

More... »

Covance Acquires Swiss Pharma Contract

Tuesday, March 24, 2009 07:43 AM

Covance has expanded its clinical pharmacology presence in Europe with the recent acquisition of Swiss Pharma Contract, a contract research organization (CRO) in Basel, Switzerland, for an undisclosed sum.

More... »

Covance Expands Presence in Ukraine, Slovakia and Israel

Wednesday, February 4, 2009 10:00 AM

Covance opened three new clinical development offices in Central and Eastern Europe and the Middle East to speed clinical trials and develop strategic relationships in those areas.

More... »

Covance Revenues Up, Maintains Guidance

Thursday, January 29, 2009 04:21 PM

Covance released strong fourth quarter and year end 2008 financial results late Wednesday with revenue increases in both early and late-stage development segments.

More... »

PPD and Merck in Strategic Outsourcing Deal

Tuesday, January 6, 2009 11:25 AM

Contract research organization (CRO) PPD has entered into a strategic collaboration with Merck that will significantly expand PPD’s global central laboratory business.

More... »

Lowered Guidance Won’t Stop Covance

Monday, January 5, 2009 09:10 AM

Global contract research organization (CRO) Covance ended the year with a flurry, lowering its 2008 guidance, purchasing an equity stake in a proteomics biomarker services provider and adding four executive positions.

More... »

Covance Names New Periapproval Services Executives

Monday, December 29, 2008 11:15 AM

Global contract research organization (CRO) Covance has added three new senior executive positions to its periapproval services team. The Princeton, N.J.-based company appointed Glynis Neagle, M.D., vice president for medical affairs; Robert Bader, director for product safety services; and Thomas Noto, vice president for regulatory affairs.

More... »